LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Ranfac Corporation Takes Bone Marrow Harvesting to Next Level
Spine

Ranfac Corporation Takes Bone Marrow Harvesting to Next Level

August 25, 2015 1 min read Premium comments

Advertisement

Ranfac Corporation Takes Bone Marrow Harvesting to Next Level
Marrow Cellulation System / Courtesy of Ranfac Corporation
Secondary

Massachusetts-based Ranfac Corporation is now giving doctors the ability to percutaneously harvest a bone dowel using the systems introducer cannula.

As stated in the August 19, 2015 news release, “The Marrow Cellution System allows the user to harvest bone marrow in small amounts in a measured and controlled manner over a large geography inside the marrow space. Independent research has demonstrated that smaller aspirations over a greater sampling area increases cell yield by reducing peripheral blood contamination.”

Harlan Adler, VP of Sales and Marketing at Ranfac, told OTW, “During the development process we learned that there was a large demand to percutaneously harvest bone dowel and combine that with our high quality bone marrow aspirate to be used in a variety of procedures. By using a larger gauge needle with a swaged distal tip and developing a special extraction cannula, we are able to allow users to combine our proprietary bone marrow aspiration method with the ability to percutaneously harvest a bone dowel through a single device.”

“In one year we hope to have distribution established across of the U.S. and Europe and to see the device be incorporated into some of the larger practices in the country.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy